🇺🇸 FDA

Company profile · Sponsor

Contineum

Contineum Therapeutics

CTNM · NYSE pharma SAN DIEGO, CA, USA
Pipeline
7
Drugs
0
Patents
2

Quick answer

Contineum (CTNM) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker CTNM
Exchange NYSE
Company type pharma
Headquarters SAN DIEGO, CA, USA
SEC CIK 0001855175

Pipeline (7)

Search pipeline →

  1. PIPE-307 Dose A

    Contineum

    Relapsing Remitting Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  2. PIPE-505

    Contineum

    Sensorineural Hearing Loss

    phase 2 small molecule completed

    1 trial

  3. PIPE-791 Dose A

    Contineum

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial

  4. PIPE-307

    Contineum

    Multiple Sclerosis

    phase 1 small molecule completed

    2 trials

  5. PIPE-791

    Contineum

    Chronic Osteoarthritis Pain

    phase 1 small molecule completed

    1 trial

  6. PIPE-791

    Contineum

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 1 small molecule completed

    1 trial

  7. PIPE-791

    Contineum

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

Patents (2)

Search patents →

  1. US 12390462

    Muscarinic acetylcholine M1 receptor antagonists

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12054487

    Muscarinic acetylcholine M1 receptor antagonists

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Contineum?

Contineum (CTNM) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does Contineum sponsor?

We track 7 ClinicalTrials.gov-linked programs for Contineum, including PIPE-307 Dose A and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Contineum company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.